Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 10 | 2025 | 500 | 1.430 |
Why?
|
| Water-Electrolyte Imbalance | 3 | 2023 | 77 | 0.810 |
Why?
|
| Decision Trees | 2 | 2015 | 57 | 0.640 |
Why?
|
| Hospital Mortality | 5 | 2023 | 1064 | 0.600 |
Why?
|
| Acute Kidney Injury | 5 | 2026 | 705 | 0.600 |
Why?
|
| Heart Arrest | 2 | 2015 | 356 | 0.590 |
Why?
|
| Severity of Illness Index | 8 | 2025 | 3061 | 0.560 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 136 | 0.530 |
Why?
|
| Cardiotonic Agents | 1 | 2018 | 138 | 0.520 |
Why?
|
| Critical Illness | 8 | 2025 | 630 | 0.510 |
Why?
|
| Support Vector Machine | 1 | 2015 | 27 | 0.460 |
Why?
|
| Tranexamic Acid | 2 | 2025 | 30 | 0.410 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 293 | 0.410 |
Why?
|
| Antifibrinolytic Agents | 2 | 2025 | 46 | 0.410 |
Why?
|
| Critical Care | 4 | 2023 | 686 | 0.380 |
Why?
|
| Respiration, Artificial | 4 | 2025 | 501 | 0.340 |
Why?
|
| Biliary Atresia | 3 | 2023 | 223 | 0.330 |
Why?
|
| Lung Diseases | 2 | 2025 | 398 | 0.320 |
Why?
|
| Liver Transplantation | 4 | 2023 | 1147 | 0.320 |
Why?
|
| Cardiomyopathies | 3 | 2023 | 514 | 0.300 |
Why?
|
| Child, Preschool | 13 | 2026 | 15110 | 0.260 |
Why?
|
| Child | 19 | 2026 | 26341 | 0.260 |
Why?
|
| Multiple Organ Failure | 3 | 2021 | 145 | 0.260 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2025 | 682 | 0.250 |
Why?
|
| ROC Curve | 3 | 2018 | 613 | 0.250 |
Why?
|
| Infant | 15 | 2025 | 13352 | 0.250 |
Why?
|
| Models, Biological | 1 | 2011 | 1371 | 0.240 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2026 | 60 | 0.230 |
Why?
|
| Retrospective Studies | 16 | 2025 | 17753 | 0.230 |
Why?
|
| Nursing Service, Hospital | 1 | 2005 | 1 | 0.220 |
Why?
|
| Nursing Evaluation Research | 1 | 2005 | 10 | 0.220 |
Why?
|
| Hospital Information Systems | 1 | 2005 | 42 | 0.220 |
Why?
|
| Adolescent | 12 | 2026 | 20987 | 0.210 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2017 | 325 | 0.210 |
Why?
|
| Hemorrhage | 2 | 2025 | 487 | 0.210 |
Why?
|
| Liver Cirrhosis | 4 | 2023 | 903 | 0.200 |
Why?
|
| Fractures, Bone | 1 | 2026 | 214 | 0.190 |
Why?
|
| Heart Defects, Congenital | 3 | 2023 | 1889 | 0.190 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 1378 | 0.190 |
Why?
|
| Length of Stay | 5 | 2025 | 1421 | 0.190 |
Why?
|
| Hypernatremia | 1 | 2023 | 32 | 0.180 |
Why?
|
| Postpartum Hemorrhage | 1 | 2023 | 111 | 0.180 |
Why?
|
| Risk Factors | 8 | 2026 | 11074 | 0.180 |
Why?
|
| Hyponatremia | 1 | 2023 | 73 | 0.180 |
Why?
|
| Anticoagulants | 1 | 2026 | 605 | 0.170 |
Why?
|
| Patient Admission | 1 | 2021 | 185 | 0.160 |
Why?
|
| Natriuretic Agents | 2 | 2017 | 28 | 0.160 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 139 | 0.160 |
Why?
|
| Humans | 27 | 2026 | 131163 | 0.150 |
Why?
|
| Male | 19 | 2026 | 64957 | 0.150 |
Why?
|
| Perioperative Care | 1 | 2021 | 217 | 0.150 |
Why?
|
| Female | 19 | 2026 | 70963 | 0.150 |
Why?
|
| End Stage Liver Disease | 1 | 2021 | 193 | 0.140 |
Why?
|
| Tracheostomy | 1 | 2021 | 212 | 0.140 |
Why?
|
| Biliary Tract Diseases | 1 | 2018 | 33 | 0.140 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2018 | 66 | 0.140 |
Why?
|
| Hospitalization | 2 | 2025 | 1950 | 0.140 |
Why?
|
| Ventilators, Mechanical | 1 | 2018 | 44 | 0.130 |
Why?
|
| Chlorothiazide | 1 | 2016 | 11 | 0.130 |
Why?
|
| Nephrons | 1 | 2016 | 17 | 0.120 |
Why?
|
| Asthma | 1 | 2025 | 922 | 0.120 |
Why?
|
| Diuresis | 1 | 2016 | 44 | 0.120 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2018 | 160 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2021 | 12936 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2015 | 304 | 0.110 |
Why?
|
| Cost of Illness | 1 | 2017 | 297 | 0.110 |
Why?
|
| Algorithms | 1 | 2002 | 1680 | 0.110 |
Why?
|
| Shock | 1 | 2015 | 100 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2018 | 385 | 0.100 |
Why?
|
| Linear Models | 1 | 2015 | 688 | 0.100 |
Why?
|
| Resuscitation | 1 | 2015 | 258 | 0.100 |
Why?
|
| Case-Control Studies | 4 | 2026 | 3359 | 0.090 |
Why?
|
| Databases as Topic | 1 | 2011 | 73 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2020 | 6459 | 0.080 |
Why?
|
| Seasons | 1 | 2011 | 335 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2304 | 0.080 |
Why?
|
| Waiting Lists | 1 | 2011 | 253 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2011 | 362 | 0.070 |
Why?
|
| Prognosis | 1 | 2017 | 4886 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2009 | 234 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 2023 | 8635 | 0.060 |
Why?
|
| Ticlopidine | 1 | 2006 | 28 | 0.060 |
Why?
|
| Young Adult | 2 | 2021 | 10103 | 0.060 |
Why?
|
| Citric Acid | 1 | 2026 | 45 | 0.060 |
Why?
|
| Infusions, Intravenous | 2 | 2017 | 531 | 0.060 |
Why?
|
| Prevalence | 2 | 2026 | 2701 | 0.060 |
Why?
|
| Positive-Pressure Respiration | 1 | 2025 | 84 | 0.060 |
Why?
|
| Fibrinolytic Agents | 1 | 2006 | 182 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2904 | 0.050 |
Why?
|
| Time Factors | 2 | 2011 | 6196 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2025 | 193 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1618 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 5196 | 0.050 |
Why?
|
| Data Collection | 1 | 2005 | 370 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 156 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2025 | 247 | 0.050 |
Why?
|
| Sodium | 1 | 2023 | 280 | 0.040 |
Why?
|
| Thrombosis | 1 | 2006 | 499 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 262 | 0.040 |
Why?
|
| Disease Progression | 2 | 2018 | 2200 | 0.040 |
Why?
|
| Research Design | 1 | 2005 | 716 | 0.040 |
Why?
|
| Risk | 1 | 2002 | 726 | 0.040 |
Why?
|
| Fluid Therapy | 1 | 2020 | 141 | 0.040 |
Why?
|
| United States | 2 | 2025 | 12072 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 915 | 0.030 |
Why?
|
| Ferritins | 1 | 2018 | 104 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1483 | 0.030 |
Why?
|
| Heart-Assist Devices | 1 | 2006 | 1020 | 0.030 |
Why?
|
| Oliguria | 1 | 2017 | 20 | 0.030 |
Why?
|
| Furosemide | 1 | 2016 | 36 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2002 | 1240 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 239 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 506 | 0.030 |
Why?
|
| Diuretics | 1 | 2016 | 159 | 0.030 |
Why?
|
| Creatinine | 1 | 2017 | 398 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 732 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2825 | 0.030 |
Why?
|
| Texas | 2 | 2015 | 3686 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1118 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 577 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1173 | 0.020 |
Why?
|
| Echocardiography | 1 | 2019 | 1125 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 808 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2011 | 155 | 0.020 |
Why?
|
| Kidney | 1 | 2017 | 1282 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 241 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 5063 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 3360 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2011 | 526 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2011 | 549 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 943 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2011 | 749 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2006 | 122 | 0.010 |
Why?
|
| Warfarin | 1 | 2006 | 121 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2009 | 1117 | 0.010 |
Why?
|
| Aspirin | 1 | 2006 | 211 | 0.010 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2006 | 187 | 0.010 |
Why?
|
| Adult | 1 | 2005 | 31282 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 3711 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2006 | 800 | 0.010 |
Why?
|